vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and EXPRO GROUP HOLDINGS N.V. (XPRO). Click either name above to swap in a different company.
EXPRO GROUP HOLDINGS N.V. is the larger business by last-quarter revenue ($382.1M vs $205.4M, roughly 1.9× COLLEGIUM PHARMACEUTICAL, INC). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs 1.5%, a 6.7% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs -12.5%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $23.2M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs -0.2%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Expro is an energy services provider headquartered in Houston, Texas, United States.
COLL vs XPRO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $382.1M |
| Net Profit | $17.0M | $5.8M |
| Gross Margin | 62.5% | — |
| Operating Margin | 29.6% | 3.1% |
| Net Margin | 8.3% | 1.5% |
| Revenue YoY | 12.9% | -12.5% |
| Net Profit YoY | 35.3% | -74.9% |
| EPS (diluted) | $0.48 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $382.1M | ||
| Q3 25 | $209.4M | $411.4M | ||
| Q2 25 | $188.0M | $422.7M | ||
| Q1 25 | $177.8M | $390.9M | ||
| Q4 24 | $181.9M | $436.8M | ||
| Q3 24 | $159.3M | $422.8M | ||
| Q2 24 | $145.3M | $469.6M | ||
| Q1 24 | $144.9M | $383.5M |
| Q4 25 | $17.0M | $5.8M | ||
| Q3 25 | $31.5M | $14.0M | ||
| Q2 25 | $12.0M | $18.0M | ||
| Q1 25 | $2.4M | $13.9M | ||
| Q4 24 | $12.5M | $23.0M | ||
| Q3 24 | $9.3M | $16.3M | ||
| Q2 24 | $19.6M | $15.3M | ||
| Q1 24 | $27.7M | $-2.7M |
| Q4 25 | 62.5% | — | ||
| Q3 25 | 61.7% | — | ||
| Q2 25 | 57.7% | — | ||
| Q1 25 | 54.8% | — | ||
| Q4 24 | 54.0% | — | ||
| Q3 24 | 60.8% | — | ||
| Q2 24 | 62.5% | — | ||
| Q1 24 | 63.1% | — |
| Q4 25 | 29.6% | 3.1% | ||
| Q3 25 | 29.7% | 6.4% | ||
| Q2 25 | 18.7% | 7.7% | ||
| Q1 25 | 12.2% | 2.6% | ||
| Q4 24 | 20.9% | 7.3% | ||
| Q3 24 | 21.9% | 6.2% | ||
| Q2 24 | 32.7% | 5.9% | ||
| Q1 24 | 34.1% | 2.2% |
| Q4 25 | 8.3% | 1.5% | ||
| Q3 25 | 15.0% | 3.4% | ||
| Q2 25 | 6.4% | 4.3% | ||
| Q1 25 | 1.4% | 3.6% | ||
| Q4 24 | 6.9% | 5.3% | ||
| Q3 24 | 5.9% | 3.8% | ||
| Q2 24 | 13.5% | 3.3% | ||
| Q1 24 | 19.1% | -0.7% |
| Q4 25 | $0.48 | $0.05 | ||
| Q3 25 | $0.84 | $0.12 | ||
| Q2 25 | $0.34 | $0.16 | ||
| Q1 25 | $0.07 | $0.12 | ||
| Q4 24 | $0.36 | $0.20 | ||
| Q3 24 | $0.27 | $0.14 | ||
| Q2 24 | $0.52 | $0.13 | ||
| Q1 24 | $0.71 | $-0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $196.1M |
| Total DebtLower is stronger | — | $79.1M |
| Stockholders' EquityBook value | $301.7M | $1.5B |
| Total Assets | $1.7B | $2.3B |
| Debt / EquityLower = less leverage | — | 0.05× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $196.1M | ||
| Q3 25 | $285.9M | $197.9M | ||
| Q2 25 | $222.2M | $206.8M | ||
| Q1 25 | $197.8M | $179.3M | ||
| Q4 24 | $162.8M | $183.0M | ||
| Q3 24 | $120.0M | $165.7M | ||
| Q2 24 | $271.6M | $133.5M | ||
| Q1 24 | $318.0M | $163.2M |
| Q4 25 | — | $79.1M | ||
| Q3 25 | — | $99.1M | ||
| Q2 25 | — | $121.1M | ||
| Q1 25 | — | $121.1M | ||
| Q4 24 | — | $121.1M | ||
| Q3 24 | — | $121.1M | ||
| Q2 24 | — | $121.1M | ||
| Q1 24 | — | $40.0M |
| Q4 25 | $301.7M | $1.5B | ||
| Q3 25 | $274.8M | $1.5B | ||
| Q2 25 | $232.2M | $1.5B | ||
| Q1 25 | $234.4M | $1.5B | ||
| Q4 24 | $228.8M | $1.5B | ||
| Q3 24 | $234.3M | $1.5B | ||
| Q2 24 | $216.6M | $1.5B | ||
| Q1 24 | $222.2M | $1.3B |
| Q4 25 | $1.7B | $2.3B | ||
| Q3 25 | $1.6B | $2.3B | ||
| Q2 25 | $1.6B | $2.3B | ||
| Q1 25 | $1.6B | $2.3B | ||
| Q4 24 | $1.7B | $2.3B | ||
| Q3 24 | $1.6B | $2.3B | ||
| Q2 24 | $1.1B | $2.3B | ||
| Q1 24 | $1.1B | $2.0B |
| Q4 25 | — | 0.05× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.08× | ||
| Q1 25 | — | 0.08× | ||
| Q4 24 | — | 0.08× | ||
| Q3 24 | — | 0.08× | ||
| Q2 24 | — | 0.08× | ||
| Q1 24 | — | 0.03× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $57.1M |
| Free Cash FlowOCF − Capex | $122.4M | $23.2M |
| FCF MarginFCF / Revenue | 59.6% | 6.1% |
| Capex IntensityCapex / Revenue | 0.3% | 8.9% |
| Cash ConversionOCF / Net Profit | 7.25× | 9.89× |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $97.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $57.1M | ||
| Q3 25 | $78.4M | $63.2M | ||
| Q2 25 | $72.4M | $48.4M | ||
| Q1 25 | $55.4M | $41.5M | ||
| Q4 24 | $84.6M | $97.4M | ||
| Q3 24 | $-9.0M | $55.3M | ||
| Q2 24 | $67.4M | $-13.2M | ||
| Q1 24 | $61.9M | $29.9M |
| Q4 25 | $122.4M | $23.2M | ||
| Q3 25 | $78.3M | $39.0M | ||
| Q2 25 | $72.4M | $27.2M | ||
| Q1 25 | $54.6M | $8.4M | ||
| Q4 24 | $84.1M | $53.0M | ||
| Q3 24 | $-9.2M | $23.3M | ||
| Q2 24 | $67.1M | $-49.5M | ||
| Q1 24 | $61.4M | $-801.0K |
| Q4 25 | 59.6% | 6.1% | ||
| Q3 25 | 37.4% | 9.5% | ||
| Q2 25 | 38.5% | 6.4% | ||
| Q1 25 | 30.7% | 2.1% | ||
| Q4 24 | 46.2% | 12.1% | ||
| Q3 24 | -5.8% | 5.5% | ||
| Q2 24 | 46.2% | -10.5% | ||
| Q1 24 | 42.3% | -0.2% |
| Q4 25 | 0.3% | 8.9% | ||
| Q3 25 | 0.1% | 5.9% | ||
| Q2 25 | 0.0% | 5.0% | ||
| Q1 25 | 0.4% | 8.5% | ||
| Q4 24 | 0.3% | 10.2% | ||
| Q3 24 | 0.2% | 7.6% | ||
| Q2 24 | 0.2% | 7.7% | ||
| Q1 24 | 0.4% | 8.0% |
| Q4 25 | 7.25× | 9.89× | ||
| Q3 25 | 2.49× | 4.52× | ||
| Q2 25 | 6.05× | 2.69× | ||
| Q1 25 | 22.92× | 2.98× | ||
| Q4 24 | 6.75× | 4.23× | ||
| Q3 24 | -0.96× | 3.40× | ||
| Q2 24 | 3.44× | -0.86× | ||
| Q1 24 | 2.23× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COLL
Segment breakdown not available.
XPRO
| NLA | $130.3M | 34% |
| ESSA | $116.3M | 30% |
| MENA | $93.0M | 24% |
| Other | $42.5M | 11% |
